Home › Funds › Integral Health Asset Management, LLC › ANRO

Integral Health Asset Management, LLC position in ANRO

ALTO NEUROSCIENCE INC · Health Care

Integral Health Asset Management, LLC reported holding 500,000 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$12.8M, representing 0.83% of its reported portfolio and ranking #38 among its reported holdings. Integral Health Asset Management, LLC has disclosed ANRO holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

Latest position (Q3 2026)500.00K sh
Reported value held$12.77M
Portfolio Weight0.83%
First reportedQ4 2024
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Integral Health Asset Management, LLC's ANRO position evolved

Integral Health Asset Management, LLC first disclosed a stake in ANRO in Q4 2024 at 300,000 shares (US$1.3M). The position peaked in Q2 2026 at 500,000 shares, worth US$13.2M. Across 8 filings, Integral Health Asset Management, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 500,000 shares valued at US$12.8M. Notable position changes include a 33% increase in Q1 2025 (shares rose 2% over the following quarter), a 33% increase in Q1 2026 (shares rose 17% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2024 300.00K $1.27M New
Q1 2025 400.00K $864.00K Add
Q2 2025 400.00K $880.00K Hold
Q3 2025 400.00K $1.61M Hold
Q4 2025 375.00K $6.67M Reduce
Q1 2026 500.00K $11.24M Add
Q2 2026 500.00K $13.20M Hold
Q3 2026 500.00K $12.77M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANRO and 13F data

ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 62 other funds we track also report a position in ANRO — the largest reported positions include Alpha Wave Global, LP (US$94.7M), Commodore Capital LP (US$71.9M), EcoR1 Capital, LLC (US$57.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANRO

All ANRO fund holders →

FAQ

How long has Integral Health Asset Management, LLC held ANRO?

Integral Health Asset Management, LLC has disclosed ANRO holdings in 8 of the last 8 reported quarters, going back to Q4 2024.

What is Integral Health Asset Management, LLC's current position in ANRO?

As of Q3 2026, Integral Health Asset Management, LLC holds 500.00K shares of ANRO (ALTO NEUROSCIENCE INC), valued at $12.77M, representing 0.83% of its reported portfolio and ranking #38.

Has Integral Health Asset Management, LLC been buying or selling ANRO?

In the latest 13F filing (Q3 2026), Integral Health Asset Management, LLC held unchanged its position in ANRO. The position peaked in Q2 2026 at 500.00K shares.

Which other funds hold ANRO?

Other major institutional holders of ANRO include Alpha Wave Global, LP, Commodore Capital LP, EcoR1 Capital, LLC, among 62 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.